The cancer letter - annual institution-wide online subscription to cancer research and drug development content

Ended Purchase Order Awarded Last action

Contract number
75N91018P00709
Awardee
Awarding agency
Obligated
$76,500

Award facts

Opportunity
Contract value 100% obligated
$76,500.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
511120 Periodical Publishers
PSC
D317 It And Telecom- Web-Based Subscription
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Washington, DC 20016, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The National Cancer Institute awarded a purchase order to Cancer Letter Inc. for an annual institution-wide online subscription to Cancer research and drug development content, valued at $76,500, on September 21, 2018. Performance is located in Washington, DC. The order is firm fixed price with no set-aside. The ultimate completion date is September 20, 2019. The originating solicitation posted on August 16, 2018, with a due date of August 29, 2018.

Quick answers

Who was awarded contract 75N91018P00709?

75N91018P00709 was awarded to Cancer Letter Inc. by National Cancer Institute (National Institutes of Health) on September 21, 2018.

How much is contract 75N91018P00709 worth?

The government has obligated $76,500 on 75N91018P00709.

Was contract 75N91018P00709 competed?

The extent of competition for 75N91018P00709 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login